Back to search
FDAFDA · Food and drugs·Recall number D-0298-2026

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01

Published February 4, 2026 · Recall initiated: December 19, 2025

Summary

FDA records drug Class II recall D-0298-2026, published February 4, 2026 and initiated December 19, 2025. Recalling firm: Sato Pharmaceutical Co., Ltd; Status: Ongoing; Reported quantity: 3,640 bottles; Lot: Lot#: PWXT, Exp 1/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Disintegration Specifications: above the time expected.

What to do

Voluntary: Firm initiated · Letter

Get an email if INON ACE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
INON ACE
Manufacturer
Sato Pharmaceutical Co., Ltd
Distributor
CA and HI
UPC
0349873402017
Lot
Lot#: PWXT, Exp 1/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
Japan

Related recalls

Questions about this recall

Was INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 recalled?

Yes. FDA published recall D-0298-2026 on February 4, 2026. Reported hazard: Failed Disintegration Specifications: above the time expected.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: INON ACE. UPC: 0349873402017.